These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21723443)

  • 21. Normo- and hyperandrogenic women with polycystic ovary syndrome exhibit an adverse metabolic profile through life.
    Pinola P; Puukka K; Piltonen TT; Puurunen J; Vanky E; Sundström-Poromaa I; Stener-Victorin E; Lindén Hirschberg A; Ravn P; Skovsager Andersen M; Glintborg D; Mellembakken JR; Ruokonen A; Tapanainen JS; Morin-Papunen LC
    Fertil Steril; 2017 Mar; 107(3):788-795.e2. PubMed ID: 28089571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic phenotype in the brothers of women with polycystic ovary syndrome.
    Sam S; Coviello AD; Sung YA; Legro RS; Dunaif A
    Diabetes Care; 2008 Jun; 31(6):1237-41. PubMed ID: 18332151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Apolipoprotein A-I and B levels, dyslipidemia and metabolic syndrome in south-west Chinese women with PCOS.
    Zhang J; Fan P; Liu H; Bai H; Wang Y; Zhang F
    Hum Reprod; 2012 Aug; 27(8):2484-93. PubMed ID: 22674204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.
    Sam S; Legro RS; Bentley-Lewis R; Dunaif A
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4797-802. PubMed ID: 15899949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome.
    Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B
    Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The phenotype of hirsute women: a comparison of polycystic ovary syndrome and 21-hydroxylase-deficient nonclassic adrenal hyperplasia.
    Pall M; Azziz R; Beires J; Pignatelli D
    Fertil Steril; 2010 Jul; 94(2):684-9. PubMed ID: 19726039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovaries are common in women with hyperandrogenic chronic anovulation but do not predict metabolic or reproductive phenotype.
    Legro RS; Chiu P; Kunselman AR; Bentley CM; Dodson WC; Dunaif A
    J Clin Endocrinol Metab; 2005 May; 90(5):2571-9. PubMed ID: 15713728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D; Tziomalos K; Macut D; Delkos D; Betsas G; Misichronis G; Katsikis I
    Fertil Steril; 2012 Feb; 97(2):494-500. PubMed ID: 22192350
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prolactin is associated with metabolic risk and cortisol in 1007 women with polycystic ovary syndrome.
    Glintborg D; Altinok M; Mumm H; Buch K; Ravn P; Andersen M
    Hum Reprod; 2014 Aug; 29(8):1773-9. PubMed ID: 24903198
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study.
    Valkenburg O; Steegers-Theunissen RP; Smedts HP; Dallinga-Thie GM; Fauser BC; Westerveld EH; Laven JS
    J Clin Endocrinol Metab; 2008 Feb; 93(2):470-6. PubMed ID: 18056772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of adrenal hyperandrogenism on the clinical and metabolic phenotype of women with polycystic ovary syndrome.
    Alpañés M; Luque-Ramírez M; Martínez-García MÁ; Fernández-Durán E; Álvarez-Blasco F; Escobar-Morreale HF
    Fertil Steril; 2015 Mar; 103(3):795-801.e2. PubMed ID: 25585504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Racial and ethnic differences in the prevalence of metabolic syndrome and its components of metabolic syndrome in women with polycystic ovary syndrome: a regional cross-sectional study.
    Chan JL; Kar S; Vanky E; Morin-Papunen L; Piltonen T; Puurunen J; Tapanainen JS; Maciel GAR; Hayashida SAY; Soares JM; Baracat EC; Mellembakken JR; Dokras A
    Am J Obstet Gynecol; 2017 Aug; 217(2):189.e1-189.e8. PubMed ID: 28400308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial and ethnic differences in the polycystic ovary syndrome metabolic phenotype.
    Engmann L; Jin S; Sun F; Legro RS; Polotsky AJ; Hansen KR; Coutifaris C; Diamond MP; Eisenberg E; Zhang H; Santoro N;
    Am J Obstet Gynecol; 2017 May; 216(5):493.e1-493.e13. PubMed ID: 28104402
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables.
    Holte J; Bergh T; Berne C; Lithell H
    Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evidence for competing effects of body mass, hyperinsulinemia, insulin resistance, and androgens on leptin levels among lean, overweight, and obese women with polycystic ovary syndrome.
    Remsberg KE; Talbott EO; Zborowski JV; Evans RW; McHugh-Pemu K
    Fertil Steril; 2002 Sep; 78(3):479-86. PubMed ID: 12215321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Müllerian-inhibiting substance reflects ovarian findings in women with polycystic ovary syndrome better than does inhibin B.
    Chu MC; Carmina E; Wang J; Lobo RA
    Fertil Steril; 2005 Dec; 84(6):1685-8. PubMed ID: 16359965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triglycerides as a Metabolic Target in Afrocaribbean Infertile Women with Polycystic Ovary Syndrome.
    Brouzeng C; Bachelot A; Moriniere C; Vaillant J; Joguet G; Velayoudom FL
    Metab Syndr Relat Disord; 2019 Dec; 17(10):500-504. PubMed ID: 31592705
    [No Abstract]   [Full Text] [Related]  

  • 38. Depression Over the Lifespan in a Population-Based Cohort of Women With Polycystic Ovary Syndrome: Longitudinal Analysis.
    Greenwood EA; Yaffe K; Wellons MF; Cedars MI; Huddleston HG
    J Clin Endocrinol Metab; 2019 Jul; 104(7):2809-2819. PubMed ID: 30985868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of self-reported ethnicity versus genetic ancestry on phenotypic characteristics of polycystic ovary syndrome (PCOS).
    Louwers YV; Lao O; Fauser BC; Kayser M; Laven JS
    J Clin Endocrinol Metab; 2014 Oct; 99(10):E2107-16. PubMed ID: 24960542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study.
    Knochenhauer ES; Key TJ; Kahsar-Miller M; Waggoner W; Boots LR; Azziz R
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3078-82. PubMed ID: 9745406
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.